Upgrade to Pro — share decks privately, control downloads, hide ads and more …

VERTOS 2 PNM.Lohle

02a9977d1d0662421ee64fc05f765281?s=47 journeevertebro
June 17, 2013
37

VERTOS 2 PNM.Lohle

11H40 12H00 VERTOS 2 PNM.Lohle

02a9977d1d0662421ee64fc05f765281?s=128

journeevertebro

June 17, 2013
Tweet

Transcript

  1. VERTOS II Percutaneous vertebroplasty versus Conservative therapy in acute osteoporotic

    VCFs Paul NM Lohle, interventional radiologist, MD PhD St Elisabeth Hospital, Tilburg, The Netherlands CAH Klazen, J de Vries, FH Jansen, AV Tielbeek, M Blonk, A. Venmans, WJ van Rooij, MC Schoemaker, JR Juttmann, TH Lo, HJJ Verhaar, Y van der Graaf, KJ van Everdingen, A. Muller, OE Elgersma, DR Halkema, H Fransen, X Janssens, E Buskens, WPThM Mali
  2. Paul NM Lohle CAH Klazen, J de Vries, FH Jansen,

    AV Tielbeek, M Blonk, A. Venmans, WJ van Rooij, MC Schoemaker, JR Juttmann, TH Lo, HJJ Verhaar, Y van der Graaf, KJ van Everdingen, A. Muller, OE Elgersma, DR Halkema, H Fransen, X Janssens, E Buskens, WPThM Mali
  3. Introduction • since the introduction of PV, PV is increasingly

    used for treatment of pain in patients with osteoporotic VCFs. Prof. Deramond Amiens
  4. Vertos II patients 202 101 101 Percutaneous Vertebroplasty Conservative therapy